Your support drives research nationally

Your Support banner

Crohn’s and Colitis Canada is able to fund these important research activities and more, thanks to your support.


GIA - Grants-in-Aid of Research: These are investigator driven research that fall under 4 domains: finding causes and triggers,

INN - The Innovation in IBD grant aims to finance creative and original methods for conducting research on inflammatory bowel disease (IBD). It is designed to encourage and facilitate research that may not fit into the conventional framework of medical research.

PACE - The Promoting Access and Care through Centres of Excellence (PACE) network brings together leading inflammatory bowel disease centres from across the country to improve health outcomes, address gaps in care, and develop solutions that can create changes in the public healthcare system.

The New Frontiers Award - A cutting-edge initiative that seeks to empower researchers to explore novel and innovative approaches to tackling inflammatory bowel disease (IBD).

GEM - The Genetic, Environmental, Microbial (GEM) Project is a global research study that looks to uncover possible triggers of Crohn’s disease.

CIRC - The Canadian Inflammatory Bowel Disease Research Consortium is a network of clinician scientists working together to promote and conduct clinical research in inflammatory bowel diseases through collaboration of multiple Canadian centres.

CANIBD - A Community of Practice for nurses working across Canada in the field of inflammatory bowel disease (IBD) with a vision of improving the quality of care of people living with IBD.

Early Career Researchers

Research Across Canada map

Table of Funded Research

Program Study Title Funding Start year Amount Funded in 2022
IIN Understanding how proteins protect the gut from harmful bacteri 2022 $44,239
IIN Investigating immune mechanisms underlying ulcerative colitis in the elderly 2022 $49,828
IIN Unravelling the link between Crohn’s disease and Type-2 diabetes 2022 $50,000
GIA Understanding the causes of ulcerative colitis using a new lab model 2022 $62,500
GIA Understanding inflammatory arthritis among people living with IBD 2022 $46,490
GIA Understanding how microbes and viruses affect colitis 2022 $62,500
GIA Function of follicular dendritic cell secreted protein in ulcerative colitis 2022 $62,470
GIA Unravelling the link between Crohn’s disease and Type-2 diabetes 2022 $62,500
GIA Understanding how E.Coli infects the lining of the colon among colitis patients 2022 $62,500
GIA Understanding how proteins protect the gut from harmful bacteria 2022 $62,500
GIA Deciphering the role of the gut microbiota in the development of Crohn’s disease 2022 $62,450
GIA The role of microbial metabolism in food intolerances associated with inflammatory bowel disease 2021 $62,500
GIA Ascertaining population-based long-term outcomes in infl ammatory bowel disease patients with primary  sclerosing cholangitis 2021 $31,250
GIA Defining time-trends, regional variations, and impact of health-care utilization on pregnancy outcomes in women with inflammatory bowel disease 2021 $43,309
GIA Novel P2Y6 antagonists as a potential therapy for infl ammatory bowel disease 2021 $125,000
GIA The use of SGLT2 inhibitors in the treatment of infl ammatory bowel disease 2021 $62,500
GIA Role of the gut mucin sialome in protection from microbiota-driven colitis 2021 $62,500
GIA Using intestinal organoids to model chronic injury and repair in IBD 2021 $31,250

Learn how IBD Champion, Peter Dobranowski is paying forward the support he's received from the IBD community and Crohn's and Colitis Canada >

  • Canada has among the highest incidence rates of Crohn's and colitis in the world.
  • 1 in 140 Canadians lives with Crohn’s or colitis.
  • Families new to Canada are developing these diseases for the first time.
  • Incidence of Crohn’s in Canadian kids under 10 has doubled since 1995.
  • People are most commonly diagnosed before age 30.

Other Areas of Interest